<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="49138">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02466529</url>
  </required_header>
  <id_info>
    <org_study_id>SMA-NHR10311</org_study_id>
    <nct_id>NCT02466529</nct_id>
  </id_info>
  <brief_title>Natural History of Spinal Muscular Atrophy Type 1 in Taiwan</brief_title>
  <official_title>Natural History of Spinal Muscular Atrophy Type 1 in Taiwan</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Kaohsiung Medical University Chung-Ho Memorial Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Biogen</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>Taipei Medical University WanFang Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Taipei Veterans General Hospital, Taiwan</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Mackay Memorial Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Chang Gung Memorial Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>China Medical University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Chung Shan Medical University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Changhua Christian Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Taichung Veterans General Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Chi Mei Medical Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Cathay General Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Shin Kong Wu Ho-Su Memorial Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Kaohsiung Veterans General Hospital.</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>National Cheng-Kung University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Buddhist Tzu Chi General Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Kaohsiung Medical University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Taipei Medical University Shuang Ho Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>National Taiwan University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Taipei Medical University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Kaohsiung Medical University Chung-Ho Memorial Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Spinal muscular atrophy (SMA) is an autosomal recessive disorder characterized by
      degeneration of motor neurons in the spinal cord and caused by mutations of the survival
      motor neuron 1 gene (SMN1).

      The investigators will conduct a systematic review of the contents and activities collected
      via a comprehensive case report form. Patients who fulfilled diagnostic criteria for SMA
      type 1 will be reviewed retrospectively.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The primary objective of this study is to investigate the natural history of spinal muscular
      atrophy (SMA) type 1 among patients in Taiwan. This study will provide further insights into
      the clinical course and pathogenesis of SMA. Several analyses will be conducted regarding
      overall survival, respiratory support, and nutritional support. The following outcome
      variables will be examined: correlation between SMA genotype and phenotype, survival, Age of
      onset and confirmed diagnosis, proportion of patients using respiratory support
      (non-invasive and invasive, reported as combined and separately), time to first use of
      respiratory support (non-invasive and invasive, reported as combined and separately),
      proportion of patients on permanent ventilation and time to permanent ventilation, number
      and average duration of hospitalizations, proportion of patients with gastrostomy, number of
      non-serious and serious respiratory infections, trend of growth parameter (e.g., weight).
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Active, not recruiting</last_known_status>
  <start_date>June 2015</start_date>
  <completion_date type="Anticipated">March 2016</completion_date>
  <primary_completion_date type="Anticipated">March 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>age of death</measure>
    <time_frame>up to 20 years</time_frame>
    <description>participants will be followed till the age of death</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>age of permanent ventilation</measure>
    <time_frame>up to 20years</time_frame>
    <description>participants will be followed till ventilation used &gt;= 16 hours/day for consecutive 21 days</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Spinal Muscular Atrophy (SMA)</condition>
  <arm_group>
    <arm_group_label>Spinal Muscular Atrophy, infant</arm_group_label>
    <description>infants diagnosed spinal muscular atrophy</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Spinal muscular atrophy Type 1
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Jan. 1987~ 30 Jun. 2014 diagnosed with Spinal Muscular Atrophy (SMA)Type 1

          -  Onset of paralytic floppy infant less than 6 months of age

          -  Generalized hypotonia and symmetric weakness, which weakness is more severe in
             proximal than distal part of extremities

          -  Weakness in the legs is greater than in the arms

          -  Tendon reflexes are absent

          -  Neurogenic changes in electromyogram and/or muscle pathology

          -  SMN1 gene deletion or mutation

        Exclusion Criteria:

          -  Non-5q SMA (no deletion or mutation of SMN1 gene)

          -  SMA type 2, type 3 or type 4 (onset of SMA after 6 months of age)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>20 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>March 2015</verification_date>
  <lastchanged_date>July 27, 2015</lastchanged_date>
  <firstreceived_date>June 2, 2015</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Atrophy</mesh_term>
    <mesh_term>Muscular Atrophy, Spinal</mesh_term>
    <mesh_term>Muscular Atrophy</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
